Effect of Moxibustion for Improving Anorexia and Quality of Life in Metastatic Cancer Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001155

Enrollment

Registered

2014-07-07

Start date

2015-02-26

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The aim of this study is to evaluate the effect and safety of moxibustion treatment for improving anorexia and quality of life(QOL) in metastatic cancer patients. Participants are tr

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Age 18 years or older, histologically or cytologically documented cancer, radiologically diagnosed metastatic cancer 2) Complain of more than 4 points when we evaluate the grade of anorexia using Visual Analogue Scale(VAS) 3) Eastern Cooperative Oncology Group (ECOG) performance status =2 4) People who volunteered to participate in this clinical study and signed the informed consent

Exclusion criteria

Exclusion criteria: 1) People who intend to receive chemotherapy or radiotherapy during the study period 2) People who have received chemotherapy or radiotherapy in the 4 weeks prior to the study 3) People who have local skin problems at or near the moxibution sites 4) People who have impossible oral intake, severe insomnia or depression 5) People who have diseases which can influence on appetite (such as hypoadrenalism, etc) 6) People who are receiving appetizers (such as megestrol acetate, corticosteroids, etc) 7) Others who are judged to be difficult to perform the clinical study

Design outcomes

Primary

Measure	Time frame
the change of anorexia cachexia subscale(ACS) score among FAACT	—

Secondary

Measure	Time frame
the change of other scores besides anorexia cachexia subscale(ACS) among FAACT ;the change of WORTC QLQ-C30 scores;the change of anorexia VAS score ;the change of WBC value;the change of neutrophil value;the change of platelet value;the change of CRP value;the change of fibrinogen value	—

Countries

Korea, Republic of

Contacts

Public ContactJeon Ju-hyun

Daejeon Korean Medicine Hospital of Daejeon University

judy-orient@hanmail.net+82-42-229-6816

Outcome results